background recent studies suggest hcv infection associated progressive declines pulmonary function patients underlying pulmonary diseases asthma chronic obstructive pulmonary disease molecular studies addressed inflammatory aspects pulmonary disease plays fundamental role reactive airway diseases examined signaling normal human lung fibroblasts nhlf response hcv nucleocapsid core protein viral antigen shown modulate intracellular signaling pathways involved cell proliferation apoptosis inflammation methods nhlf treated hcv core protein assayed expression phosphorylation p38 mapk pathway effect p38 inhibition results studies demonstrate soluble hcv core protein induces significant increases mrna protein expression manner treatment hcv core led phosphorylation p38 mapk expression dependent p38 activation using tnfalpha observed additive increases expression hcv expression inhibited blocking gc1qr known receptor soluble hcv core linked mapk signaling conclusion studies suggest hcv core protein lead enhanced il8 expression role contribute progressive deterioration pulmonary function recently recognized individuals chronically infected hcv hcv associated il NUMBER il NUMBER il NUMBER il NUMBER dose time dependent il NUMBER stimulant il NUMBER core mediated il NUMBER p38 gc1qr dependent pro inflammatory